Brainomix: revolutionising stroke care through AI
23rd January 2024
This year, around 100,000 people in the UK will have a stroke. AI algorithms developed by Oxford University spinout Brainomix are ensuring that more of those patients will receive better care and better outcomes.
It’s no coincidence that the best-known acronym for spotting signs of a stroke urges FAST action. Every second counts – not least for the clinicians making crucial decisions about diagnosis and treatment.
Brainomix, a digital health trailblazer spun out of Oxford University’s preclinical stroke lab in 2010, uses state-of-the-art AI algorithms to help doctors make quick, accurate decisions for their patients. Its Brainomix 360 stroke platform analyses images from simple CT scans, providing detailed real-time information – available to view remotely – on the extent and nature of damage to the brain.
The technology is effective: studies have shown that implementing Brainomix 360 reduces arrival-to-discharge times by more than one hour, increases treatment rates by up to 55% resulting to tripling the number of stroke patients going on to achieve functional independence.
The Brainomix 360 platform – the most comprehensive tool of its kind – is the European market leader, has been adopted by more than 30 healthcare systems worldwide, has raised over £30m in public and private funding. A patient is scanned using e-Stroke every five minutes, with results available in a few minutes.
Led and co-founded by Dr Michalis Papadakis, Brainomix has now developed similar AI-powered imaging platforms for lung disease and cancer. The company is regularly showcased by government as a leader in the health data revolution.
Dr Papadakis says: “In 2023 we were delighted to receive FDA approval to take our Brainomix 360 technology to the US, where more than 800,000 people suffer a stroke each year. The Brainomix 360 package of AI technologies, supports physicians who are making time-sensitive, critical decisions around transfer and treatment, strengthening networks and facilitating an improved stroke service.”
This year, around 100,000 people in the UK will have a stroke. That’s one every five minutes. Globally, the annual number of strokes is estimated to be upwards of 12 million, making it one of the world’s leading causes of death and disability. Brainomix is ensuring that an increasing number of those people will receive better care and better outcomes – a shining example of the potential for academic spinouts to translate innovative research into real-world impact that can benefit patients and healthcare providers.Press release sign up